Epirubicin and febrile neutropenia Patient Reports February 12, 2012

Epirubicin Side Effects Report #4549586-7
Epirubicin side effect was reported by a Consumer or non-health professional from on Dec 28, 2004. Female patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, gastrointestinal disorder, growth retardation, lymph node abscess, neutropenic sepsis, rash maculo-papular, septic shock, vasculitis . Epirubicin dosage: 150 MG/M2. During the same period patient was treated with ETOPOSIDE, VINCRISTINE SULPHATE, CARBOPLATIN, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5277937-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 15, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, candida serology positive, febrile neutropenia, pneumonitis, pneumothorax, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE. Patient died.

Epirubicin Side Effects Report #5377622-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 21, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood culture positive, candida serology positive, febrile neutropenia, fungus sputum test positive, pneumonitis, respiratory failure, streptococcal infection . Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient died.

Epirubicin Side Effects Report #5407559-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, blood culture positive, candidiasis, febrile neutropenia, mucosal inflammation, pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.


Epirubicin Side Effects Report #5651720-2
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 22, 2008. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, mucosal inflammation, pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5704744-0
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2008. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, blood culture positive, candida serology positive, febrile neutropenia, mucosal inflammation, pneumonitis, respiratory failure, stridor. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE, DEXAMETHASONE, CILASTATIN, IMIPENEM. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5727855-2
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 23, 2008. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, mucosal inflammation, pneumonitis. Epirubicin dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5342511-0
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on May 21, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.

Epirubicin Side Effects Report #5362641-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 07, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.


Epirubicin Side Effects Report #5375325-6
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5403231-7
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 20, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5633443-9
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Male patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. Epirubicin dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.

Epirubicin Side Effects Report #5583284-6
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2007. Female patient, 72 years of age, was diagnosed with malignant fibrous histiocytoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: altered state of consciousness, cardiac failure, febrile neutropenia, hyponatraemia, respiratory failure, sepsis . Epirubicin dosage: DAILY DOSE:40MG-FREQ:ON DAYS 2 AND 4. During the same period patient was treated with IFOSFAMIDE, LENOGRASTIM. Patient recovered.

Epirubicin Side Effects Report #4808931-5
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2005. Male patient, weighting 94.80 lb, was diagnosed with gastric cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: chills, constipation , febrile neutropenia, laboratory test abnormal, neutrophil count decreased, treatment noncompliance. Epirubicin dosage: unknown. During the same period patient was treated with CISPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #4604189-0
Epirubicin side effect was reported by a Health Professional from on Mar 08, 2005. Female patient, 61 years of age, weighting 136.7 lb, was diagnosed with breast neoplasm and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, headache , insomnia. Epirubicin dosage: 120 MG IV PUSH. Patient recovered.

Epirubicin Side Effects Report #4604192-0
Epirubicin side effect was reported by a Health Professional from on Mar 08, 2005. Female patient, 53 years of age, weighting 85.00 lb, was diagnosed with breast neoplasm and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, infection , rash pustular. Epirubicin dosage: unknown. Patient recovered.

Epirubicin Side Effects Report #5018184-3
Epirubicin side effect was reported by a Physician from AUSTRALIA on May 17, 2006. Female patient, 38 years of age, was diagnosed with breast cancer female and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia. Epirubicin dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, TRIPTORELIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5018250-2
Epirubicin side effect was reported by a Physician from AUSTRALIA on May 17, 2006. Female patient, 38 years of age, was diagnosed with breast cancer female and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: breast cancer female, febrile neutropenia. Epirubicin dosage: unknown. During the same period patient was treated with FLUOROIURACIL, CYCLOPHOSPHAMIDE, TRIPTORELIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5047771-1
Epirubicin side effect was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient, 58 years of age, weighting 179.0 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: bronchitis , febrile neutropenia, hypocalcaemia, nasal congestion, pneumonia . Epirubicin dosage: 90 MG/M2 EVERY 3 WEEKS IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, SYNTHROID, LEVAQUIN, LORAZEPAM, COMPAZINE, TESSALON. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #4847432-5
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2005. Female patient, 57 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, fluid overload, haemoglobin decreased, hypotension, platelet count decreased, pleural effusion, pneumonia , white blood cell count decreased, white blood cell count increased. Epirubicin dosage: (100 MG/M2, CYCLE 1 OUT OF 4, EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, AVELOX, NEUPOGEN, PRILOSEC, ZOFRAN, CARAFATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5063846-5
Epirubicin side effect was reported by a Health Professional from UNITED STATES on July 26, 2006. Female patient, 49 years of age, weighting 210.0 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: diverticulitis, febrile neutropenia. Epirubicin dosage: 90MG/M2 EVERY 3 WEEKS IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, LORAZEPAM, COMPAZINE, ZOFRAN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5409612-X
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient, 38 years of age, weighting 149.0 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, jugular vein thrombosis. Epirubicin dosage: 149MG Q3WK IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5469309-7
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2007. Female patient, 38 years of age, weighting 149.0 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, jugular vein thrombosis, staphylococcal infection , subclavian vein thrombosis. Epirubicin dosage: 149MG IV Q3WK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #6138480-6
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Mar 19, 2009. Female patient, weighting 149.0 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: bacteraemia, febrile neutropenia, jugular vein thrombosis, pancytopenia. Epirubicin dosage: 149 MG EVERY 3 WEKS. During the same period patient was treated with CYCLOPHOSPHAMIDE, MYCOLOG, METHADONE, DILAUDID, PROMETHAZINE, LOVENOX. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #4749111-1
Epirubicin side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Aug 01, 2005. Female patient was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia. Epirubicin dosage: 35 MG/M2 OTH IA. During the same period patient was treated with PACLITAXEL, FLUOROURACIL, CYCLOIPHOSPHAMIDE, DEXAMETHASONE, DIPHENHYDRAMINE, CIMETIDINE, METOCLOPRAMIDE. Patient recovered.

Epirubicin Side Effects Report #4673758-4
Epirubicin side effect was reported by a Consumer or non-health professional from on May 11, 2005. Female patient, 46 years of age, was diagnosed with metastases to bone and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia. Epirubicin dosage: unknown. During the same period patient was treated with METHOTREXATE, FLUOROURACIL, ZOLEDRONIC ACID, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.